NasdaqGS - Nasdaq Real Time Price USD
Boundless Bio, Inc. (BOLD)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 4:02 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Expense
65,023.0000
54,796.0000
46,469.0000
25,301.0000
Operating Income
-65,023.0000
-54,796.0000
-46,469.0000
-25,301.0000
Net Non Operating Interest Income Expense
7,171.0000
5,282.0000
668.0000
96.0000
Other Income Expense
129.0000
80.0000
-100.0000
-5.0000
Pretax Income
-57,723.0000
-49,434.0000
-45,901.0000
-25,210.0000
Net Income Common Stockholders
-57,723.0000
-49,434.0000
-45,901.0000
-25,210.0000
Diluted NI Available to Com Stockholders
-57,723.0000
-49,434.0000
-45,901.0000
-25,210.0000
Basic EPS
-2.59
-3.53
-3.28
-1.80
Diluted EPS
-2.59
-3.53
-3.28
-1.80
Basic Average Shares
22,254.5370
13,990.0000
13,990.0000
13,990.0000
Diluted Average Shares
22,254.5370
13,990.0000
13,990.0000
13,990.0000
Total Operating Income as Reported
-65,023.0000
-54,796.0000
-46,469.0000
-25,301.0000
Total Expenses
65,023.0000
54,796.0000
46,469.0000
25,301.0000
Net Income from Continuing & Discontinued Operation
-57,723.0000
-49,434.0000
-45,901.0000
-25,210.0000
Normalized Income
-57,723.0000
-49,434.0000
-45,901.0000
-25,210.0000
Interest Income
7,171.0000
5,282.0000
668.0000
96.0000
Net Interest Income
7,171.0000
5,282.0000
668.0000
96.0000
EBIT
-65,023.0000
-54,796.0000
-46,469.0000
-25,301.0000
EBITDA
-64,013.0000
-53,839.0000
-45,527.0000
-24,619.0000
Reconciled Depreciation
1,010.0000
957.0000
942.0000
682.0000
Net Income from Continuing Operation Net Minority Interest
-57,723.0000
-49,434.0000
-45,901.0000
-25,210.0000
Normalized EBITDA
-64,013.0000
-53,839.0000
-45,527.0000
-24,619.0000
12/31/2021 - 3/28/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ARTV Artiva Biotherapeutics, Inc.
12.17
-4.77%
PROK ProKidney Corp.
1.9700
-0.51%
MGX Metagenomi, Inc.
1.9600
-1.51%
ANRO Alto Neuroscience, Inc.
14.43
+1.12%
ATXS Astria Therapeutics, Inc.
11.46
-2.55%
CTNM Contineum Therapeutics, Inc.
16.38
-0.61%
CNTX Context Therapeutics Inc.
2.0400
+1.49%
TRML Tourmaline Bio, Inc.
28.26
-2.99%
ELVN Enliven Therapeutics, Inc.
29.00
+3.50%
BCAX Bicara Therapeutics Inc.
21.96
+7.44%